Simoctocog alfa for haemophilia A: No suitable data

No added benefit can be derived from the dossier: The duration of the direct comparative studies was too short and the study pool on one-arm studies with the comparator therapy was incomplete. —> Read More Here


Leave a Reply

Your email address will not be published. Required fields are marked *